Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Renalytix Ai Plc ADR
(NQ:
RNLX
)
0.5157
+0.0026 (+0.51%)
Streaming Delayed Price
Updated: 3:56 PM EDT, May 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Renalytix Ai Plc ADR
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Monday's After-Market Session
March 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 03, 2023
Via
Benzinga
Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 09, 2023
From
Renalytix plc
Via
GlobeNewswire
Preview: Renalytix AI's Earnings
November 29, 2022
Via
Benzinga
Recap: Renalytix Q4 Earnings
October 31, 2022
Renalytix (NASDAQ:RNLX) reported its Q4 earnings results on Monday, October 31, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 08, 2023
Via
Benzinga
Why Sintx Technologies Shares Are Trading Lower By 38%; Here Are 20 Stocks Moving Premarket
February 08, 2023
Gainers PainReform Ltd. (NASDAQ: PRFX) shares rose 89.5% to $0.9475 in pre-market trading. PainReform reported receipt of extension to Aug. 7, 2023 to meet the Nasdaq's minimum bid price requirement.
Via
Benzinga
Renalytix announces a c.$20.3 million private placement
February 08, 2023
From
Renalytix plc
Via
GlobeNewswire
Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States
January 26, 2023
Award for consortium of industry, academic and clinical research leaders to develop personalized drug response tests in chronic kidney disease
From
Renalytix plc
Via
GlobeNewswire
Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems
January 09, 2023
Significant milestone will make KidneyIntelX accessible to 960,000 veterans with chronic kidney disease
From
Renalytix AI, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
December 30, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 19, 2022
Via
Benzinga
Primary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and Outcomes
December 01, 2022
First-in-class bioprognostic™ KidneyIntelX provided clear direction for primary care physicians to slow or stop progression of chronic kidney disease in adult diabetes patients
From
Renalytix AI, Inc.
Via
GlobeNewswire
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023
November 30, 2022
From
Renalytix AI, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 30, 2022
November 30, 2022
Companies Reporting Before The Bell • Seadrill (NYSE:SDRL) is expected to report earnings for its third quarter. • Build-A-Bear Workshop (NYSE:BBW) is likely to report earnings for its third quarter.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 29, 2022
Via
Benzinga
Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease
November 29, 2022
From
Renalytix AI, Inc.
Via
GlobeNewswire
Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30
November 22, 2022
From
Renalytix plc
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 16, 2022
Via
Benzinga
Renalytix to Present at Stifel Healthcare Conference
November 03, 2022
From
Renalytix plc
Via
GlobeNewswire
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
November 01, 2022
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 31, 2022
Gainers
Via
Benzinga
Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday's Mid-Day Session
October 31, 2022
Gainers 1847 Holdings LLC (NASDAQ: EFSH) shares surged 72.7% to $3.25 after the company reported it sees over $60 million in revenue and over $7 million in cash flow from operations in 2023 from its...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 31, 2022
Gainers PLx Pharma (NASDAQ:PLXP) stock increased by 15.5% to $0.7 during Monday's pre-market session. The market value of their outstanding shares is at $20.3 million.
Via
Benzinga
Renalytix Reports Full Year Fiscal 2022 Results
October 31, 2022
From
Renalytix plc
Via
GlobeNewswire
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
October 26, 2022
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 25, 2022
Gainers
Via
Benzinga
MarketBeat Podcast, 3 Small Caps With Big Upside
October 25, 2022
Today on The MarketBeat Podcast is Randy Baron, portfolio manager at Pinnacle Associates. Three stocks Randy discusses today have small market capitalizations.
Via
MarketBeat
Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31
October 24, 2022
From
Renalytix plc
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.